Filing Flows › First Busey (BUSE) › Guidance & outlook
First Busey (BUSE) guidance and outlook
First Busey's 10-Q filed Nov 5, 2026 makes 5 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 5, 2026
- The ACL is recorded in accordance with GAAP to provide an adequate reserve for expected credit losses that is reflective of management’s best estimate of what is expected to be collected.
- Management assesses the potential for loss on such loans and considers the effect of any potential loss in determining its provision for expected credit losses.
- As of September 30, 2026, management identified no other loans that represent or result from trends or uncertainties that would be expected to materially impact future operating results, liquidity, or capital resources.
- As of September 30, 2026, management believed that adequate liquidity existed to meet all projected cash flow obligations.
- The judgment and assumptions made are based upon historical experience, future forecasts, or other factors that management believes to be reasonable under the circumstances.
First Busey's latest quarter
First Busey, Q3 2026: revenue $194M (-1% year over year), operating margin 37.5%, net earnings $55.8M, operating cash flow $71.2M. The chart follows the revenue to costs, profit and cash.
Questions
What does First Busey expect?
The ACL is recorded in accordance with GAAP to provide an adequate reserve for expected credit losses that is reflective of management’s best estimate of what is expected to be collected. Management assesses the potential for loss on such loans and considers the effect of any potential loss in determining its provision for expected credit losses. As of September 30, 2026, management identified no other loans that represent or result from trends or uncertainties that would be expected to materially impact future operating results, liquidity, or capital resources.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.